CIAM
SANA icon

Caitong International Asset Management’s Sana Biotechnology SANA Stock Holding History

Caitong International Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47K Buy
+510
New +$2.01K ﹤0.01% 1312
2025
Q3 		– Sell
-3,952
Closed -$10.8K – 2442
2025
Q2 		$10.8K Buy
+3,952
New +$8.15K 0.01% 694
2025
Q1 		– Sell
-843
Closed -$1.37K – 2483
2024
Q4 		$1.37K Buy
+843
New +$2.51K ﹤0.01% 1257

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Caitong International Asset Management's SANA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Sana Biotechnology (SANA) in Q1 2026: 510 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #1312 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in SANA as recently as Q2 2025.

Caitong International Asset Management first reported a position in SANA in Q4 2024 and has held it in 3 quarters since. The position peaked at $10.8K in Q2 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Caitong International Asset Management held 510 shares of Sana Biotechnology worth $1.47K as of Q1 2026.
  • Sana Biotechnology was a new Caitong International Asset Management position in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1312 holding.
  • Caitong International Asset Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's Sana Biotechnology position peaked at $10.8K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.